CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, has announced that the 100th patient has received treatment for communicating hydrocephalus with the eShunt System. The 100 patients were enrolled in pilot studies and in the STRIDE clinic
Cardiosense, a medical AI company transforming cardiovascular disease management has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CardioTag device, the first multimodal, wearable sensor that simultaneously captures high-fidelity electrocardiogram (E
Glasgow-based company CardioPrecision has successfully executed the first clinical cases of robotic aortic valve replacement through a tiny incision in the neck. Last year, the global leader in transcervical access for the treatment of structural heart disease demonstrated a proof-of-concept AVATAR
Sanome, a company building Clinical Decision Support tools to detect emerging health risks, has secured Class IIb CE certification and MHRA approval for MEMORI – an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs) – at the same time as appointi
Cartherics, a biotechnology company developing off-the-shelf immune stem cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has unveiled its new cleanroom facility for clinical-scale manufacturing of cell therapy products. The facility wa
Samuel Bateman is a senior associate and patent attorney, and Chris Froud is a partner and patent attorney, at European IP firm, Withers & Rogers. Both specialise in advising innovative companies and developers in electronics and computing. The combination of enhanced imaging technologies and AI-pow
Sony Healthcare Solutions Europe and Siemens Healthineers have announced a strategic global collaboration that combines ARTIS, the high-end angiography system of Siemens Healthineers, with Sony’s cutting-edge NUCLeUS audio-visual management platform. Through the strategic alliance, the ARTIS systems
Ultromics, a pioneer in AI-driven cardiology diagnostics solutions, has announced it has raised 55 million USD through its Series C funding round. The funding round was co-led by L&G, Allegis Capital, and Lightrock. It also received continued support from Oxford Science Enterprises, GV, Blue Venture
Dxcover has announced the strategic expansion of its Scientific Advisory Board (SAB) and Board of Directors. These appointments bring world-class expertise across neurology, gynaecological and pancreatic oncology, clinical statistics, artificial intelligence, and commercial diagnostics – strengtheni
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a new consultation launched by NICE. The National Institute for Health and Care Excellence (NICE) has launched a consultation see
With over 363,000 children waiting for consultant-led paediatric care in England last year alone, timely access to care remains a pressing challenge for the NHS. But beyond waiting lists, a quieter risk persists – outdated or non-compliant medical equipment still widely used in children’s wards acro
Andy Pidgeon, Head of Usability at 42 Technology argues too many devices are designed for mythical users. We need to innovate for people, not for platforms. Smart auto-injectors, wearable patches, Bluetooth apps, voice prompts, cloud dashboards, even AI nudges. More technologies than ever are being
